氟比洛芬酯对前列腺电切手术超前镇痛的临床研究  被引量:2

Clinical Research about Flurbiprofen Used for Preemptive Analgesiain Patients undergo TURP Surgery

在线阅读下载全文

作  者:张永强[1] 

机构地区:[1]河南新乡医学院一附院麻醉科,453100

出  处:《中国医药指南》2010年第13期177-179,共3页Guide of China Medicine

摘  要:目的观察氟比洛芬酯对于前列腺电切手术(TURP)的超前镇痛作用。方法 60例前列腺增生(BPH)患者随机分成A、B、C三组,每组各20例,均在连续硬膜外麻醉下行经尿道前列腺电切术(TURP)。A组术前30min静注氟比洛芬醋50mg,术毕静注生理盐水10mL。B组于术前30min静注生理盐水10mL,术毕时静注氟比洛芬酯50mg。C组在手术前后均静注生理盐水10mL。术后用视觉模拟评分法(VAS)单盲评估患者术后1、2、6、12、24、48h疼痛感觉程度和与氟比洛芬酯有关的不良反应。结果 A组术后24hVAS评分显著低于C组(P<0.05),B组1h、2hVAS评分与C组无显著性差异(P>0.05),6、12、24h显著低于C组(均P<0.05),3组48hVAS评分无显著性差异(P>0.05)。结论氟比洛芬酯对TURP患者具有良好的超前镇痛作用,且无明显不良反应。Objective To assess the effects of preemptive analgesia with flurbiprofen on the postoperative pain for patients who were undergoing TURP surgery. Methods Sixty cases scheduled for selective TURP surgery were randomLy divided into A, B and C groups, they were all adopted by continuous epidural anesthesia. Thirty minutes before operation, the patients in group A received flurbiprofen 50mg intravenously.After operation, the patients in group B received flurbiprofen 50mg and group A, group C received normal saline 10mL.The effects of analgesia after operation were assessed by visual analogue scale (VAS) at1, 2, 6, 12, 24, 48hours after operation and side effects were also assessed. Results The VAS of group A was lower than that of group C during 24 hours after operation(P0.05), The VAS were same between group B and group C at the time point of 1, 2 hour(P0.05). The VAS of group B was lower than that of group C at the time point of 6, 12, 24 hour(P0.05). The VAS were same in the three groups at the time point of 48 hour(P0.05). Conclusion Preemptive analgesia with flurbiprofen 1mg/kg could provide satisfactory pain relief with no obvious side effects during 24 hours after TURP surgery.

关 键 词:氟比洛芬酯 超前镇痛 前列腺电切手术 

分 类 号:R697.3[医药卫生—泌尿科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象